Skip to content

Clinical trials

Phase 2 Carcinoma, Transitional Cell trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Transitional Cell Phase: Phase 2 Country / region: France Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20082
20101
20112
20161
20172
20181
20192
20201
20213
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated6
Recruiting3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation3
Bristol-Myers Squibb2
AbbVie1
Achieve Life Sciences1
Acrotech Biopharma Inc.1
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie1
Astellas Pharma Inc1
Centre Francois Baclesse1
Centre Hospitalier Universitaire de Nīmes1
Centre Hospitalier Universitaire de Saint Etienne1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Transitional Cell22
Urinary Bladder Neoplasms12
Neoplasm Metastasis4
Ureteral Neoplasms3
Urologic Neoplasms3
Acrocephalosyndactylia2
Neoplasms2
Urethral Neoplasms2
Carcinoma1
Kidney Neoplasms1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.